Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-29

Clinical Trial Update: Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313

View source ↗

Summary

Completed clinical trial assessing posterior capsule opacification after cataract surgery with the MICS IOL L313.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MICS IOL L313 (intraocular lens)

Snippet

Sponsor: Dietrich-Bonhoeffer-Klinikum | Conditions: Posterior Capsule Opacification | Status: COMPLETED | Results posted: 2020-04-29